Vanda Pharmaceuticals | Ativo Circulante



Current Assets Alterar Data
Acadia Pharmaceuticals USD 870.94M 67.38M 2025-03
Agios Pharmaceuticals USD 968.62M 3.02M 2025-03
Alnylam Pharmaceuticals USD 3.27B 27.03M 2025-03
Arrowhead Research USD 1.14B 564.68M 2025-03
AstraZeneca USD 26.14B 312M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Eli Lilly USD 41.26B 8.52B 2025-03
Halozyme Therapeutics USD 1.26B 176.69M 2025-03
Insmed USD 1.4B 218.97M 2025-03
J&J USD 71.55B 15.66B 2025-03
Ligand Pharmaceuticals USD 309.32M 22.24M 2025-03
Merck USD 35.5B 3.28B 2025-03
Moderna USD 6.77B 1.33B 2025-03
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 45.86B 4.5B 2025-03
PTC Therapeutics USD 2.32B 950.88M 2025-03
Sanofi 44.02B 1.43B 2025-03
Takeda JPY 2.52T 233.1B 2025-03
Teva Pharmaceutical Industries USD 11.53B 1.02B 2025-03
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
Veracyte USD 383.15M 10.88M 2025-03



Vanda Pharmaceuticals Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jul 2025.